Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Spain
Clinical trial register · Spain

Clinical Trials in Spain

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5909 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
5909
Studies in scope
all four open statuses
3100
Recruiting now
open to new participants
1129
Lead sponsors
across recruiting studies
Top sites
Madrid 79 Barcelona 58 Valencia 40 Seville 29 Majadahonda 22
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca221 Novartis Pharmaceuticals151 Merck Sharp & Dohme LLC133 Janssen Research & Development, LLC125 Hoffmann-La Roche118 AbbVie103 Eli Lilly and Company102 Pfizer82 Bristol-Myers Squibb79 Sanofi67 GlaxoSmithKline66 University of Valencia64 Amgen54 Boehringer Ingelheim53 Hospital Universitari Vall d'Hebron Research Institute48 Novo Nordisk A/S43 Universidad Complutense de Madrid40 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau39 Hospital Clinic of Barcelona39 Takeda38 Regeneron Pharmaceuticals38 Daiichi Sankyo34 Gilead Sciences33 Universidad de Granada32 Bayer32 Show all 1646 Clear sponsor filter
Site location
Madrid79 Barcelona58 Valencia40 Seville29 Majadahonda22 Pamplona20 Málaga17 Santander17 Santiago de Compostela17 Badalona17 Córdoba16 A Coruña16 L'Hospitalet de Llobregat13 Las Palmas de Gran Canaria12 Sabadell10 Zaragoza9 Esplugues de Llobregat8 Ferrol7 Granada7 Salamanca7 León5 Alcorcón5 Jaén5 Oviedo4 Manises4 Show all 65
All 65 locations
Target enrolment
to

Trials in this register

103 of 5909 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
AbbVie
Phase 3
520
Santander, Pamplona, Madrid
2026-11-30
Recruiting
AbbVie
Observational
100
Sant Joan Despí
2026-08-03
Recruiting
AbbVie
Phase 3
531
Barcelona, Madrid
2026-07-02
Recruiting
AbbVie
Phase 2/3
660
Majadahonda, Pamplona, Seville, Madrid, Valencia
2026-06-30
Recruiting
AbbVie
Phase 3
990
Barcelona, Córdoba, Madrid, Valencia, Zaragoza
2026-05-22
Recruiting
AbbVie
Phase 2
165
Valencia
2026-01-23
Recruiting
AbbVie
Phase 2/3
680
Santiago de Compostela, Badalona, Santander, Las Palmas de Gran Canaria, Pamplona, Barcelona, León, Madrid
2026-01-08
Recruiting
AbbVie
Phase 2/3
490
Santiago de Compostela, Sabadell, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2025-12-10
Recruiting
AbbVie
Phase 2
100
Pamplona, Barcelona, Madrid, Valencia
2025-12-01
Recruiting
AbbVie
Phase 1
285
Majadahonda, Barcelona, Madrid
2025-11-27
Recruiting
AbbVie
Phase 2
180
Málaga, A Coruña, Barcelona, Madrid
2025-11-25
Recruiting
AbbVie
Observational
103
Málaga, Palma, Badalona, Santander, Cartagena, Gijón, Seville, Almería
2025-11-17
Recruiting
AbbVie
Phase 2
400
Santander, Donostia / San Sebastian, Las Palmas de Gran Canaria, Majadahonda, Seville, A Coruña, Barcelona, Girona
2025-11-13
Recruiting
AbbVie
Phase 3
561
Córdoba, Donostia / San Sebastian, Majadahonda, Asturias, Seville, Barcelona, Madrid, Valencia
2025-11-05
Recruiting
AbbVie
Observational
700
Málaga, León, Cartagena, El Palmar, Murcia, Pontevedra, Toledo
2025-09-09
Recruiting
AbbVie
Observational
2,795
Jaén, Alcorcón, Majadahonda, Parla, San Cristóbal de La Laguna, Valencia
2025-09-02
Recruiting
AbbVie
Phase 2
140
Seville, Madrid, Salamanca
2025-09-02
Recruiting
AbbVie
Phase 2/3
854
Barcelona, Madrid, Valencia
2025-08-03
Recruiting
AbbVie
Phase 3
120
A Coruña, Majadahonda
2025-07-28
Recruiting
AbbVie
Phase 2
180
Sabadell, Seville, Bilbao, A Coruña, Córdoba, Madrid, Valencia
2025-06-20
Active, closed
AbbVie
Phase 3
573
Santiago de Compostela, Granollers, Manresa, Las Palmas de Gran Canaria, Alcorcón, Majadahonda, Gijón, Seville
2025-06-17
Recruiting
AbbVie
Phase 2
110
Badalona, Jaén, El Palmar, Pamplona, Seville, Barcelona, Madrid, Valencia
2025-05-28
Recruiting
AbbVie
Phase 2
390
Santander, Pamplona, Barcelona, Madrid, Valencia
2025-04-24
Recruiting
AbbVie
Phase 1
232
Madrid
2025-04-14
Recruiting
AbbVie
Observational
700
A Coruña, Badalona, Sabadell, Córdoba, Marbella, Pamplona, Seville, Manises
2025-03-28
Recruiting
AbbVie
Phase 1/2
252
Santander, Seville, A Coruña, Alicante, Barcelona, Málaga
2025-03-06
Active, closed
AbbVie
Phase 3
468
Barcelona, Madrid, Valladolid
2025-02-10
Recruiting
AbbVie
Observational
1,200
Málaga, Lorca, Vigo, Seville, Granada, Huelva, Madrid, Murcia
2025-01-31
Active, closed
AbbVie
Phase 2
150
Barcelona, Madrid, Seville
2025-01-20
Active, closed
AbbVie
Phase 2
185
Pamplona, Madrid, Ourense, Valencia
2024-12-13
Active, closed
AbbVie
Observational
1,314
Málaga, L'Hospitalet de Llobregat, Leganés, Majadahonda, Oviedo, Seville, Barcelona, Madrid
2024-11-26
Active, closed
AbbVie
Phase 2
309
Badajoz, Barcelona, Madrid, Valencia
2024-10-07
Recruiting
AbbVie
Phase 2
590
Santiago de Compostela, Seville, Barcelona, Madrid, Pontevedra, Valencia
2024-09-04
Active, closed
AbbVie
Phase 3
699
Esplugues de Llobregat, Madrid, Valencia, Zaragoza
2024-08-19
Active, closed
AbbVie
Phase 3
111
Ferrol, Esplugues de Llobregat, Málaga, Seville, Zaragoza
2024-08-08
Recruiting
AbbVie
Phase 3
170
Santiago de Compostela, Majadahonda, Pamplona, Madrid, Seville
2024-08-05
Active, closed
AbbVie
Phase 2
108
Barcelona, Cáceres, Jaén, Madrid, Valencia
2024-07-29
Recruiting
AbbVie
Phase 3
40
Esplugues de Llobregat, Valencia
2024-07-08
Active, closed
AbbVie
Phase 3
1,400
Sabadell, Santander, Manises, Madrid, Málaga, Valencia
2024-06-27
Active, closed
AbbVie
Phase 3
184
Granada, Madrid, Valencia
2024-06-14
Active, closed
AbbVie
Phase 3
421
Badalona, Ourense, León, Madrid, Salamanca, Valencia
2024-05-19
Active, closed
AbbVie
Phase 2/3
167
Santiago de Compostela, L'Hospitalet de Llobregat, Barcelona, Madrid, Valencia
2024-04-10
Active, closed
AbbVie
Phase 2
156
Santiago de Compostela, Pamplona, Madrid, Seville
2024-03-23
Active, closed
AbbVie
Phase 1
152
Barcelona, Madrid, Seville
2024-03-08
Active, closed
AbbVie
Observational
1,200
Sant Joan Despí, Jerez de la Frontera, Córdoba, Las Palmas de Gran Canaria, Leganés, Oviedo, Galdakao, Barcelona
2024-02-19
Active, closed
AbbVie
Observational
427
Santiago de Compostela, Elche, Majadahonda, Granada, Madrid, Seville
2024-01-24
Active, closed
AbbVie
Phase 2/3
89
Santander, Majadahonda, Barcelona, Córdoba, Madrid, Seville, Zaragoza
2024-01-11
Active, closed
AbbVie
Phase 3
614
Badalona, Getafe, Pozuelo de Alarcón, Granada, Madrid, Valencia, Zaragoza
2023-12-19
Recruiting
AbbVie
Phase 3
110
Ferrol, Madrid, Málaga
2023-12-11
Active, closed
AbbVie
Phase 2
280
Barcelona, Madrid, Valencia, Zaragoza
2023-11-12
Recruiting
AbbVie
Phase 1
325
Badalona, Pamplona, Barcelona, Madrid, Málaga, Zaragoza
2023-11-09
Active, closed
AbbVie
Phase 3
122
Ferrol, Esplugues de Llobregat, Barcelona, Málaga
2023-11-06
Active, closed
AbbVie
Observational
146
Vitoria-Gasteiz, Manresa, Terrassa, Jerez de la Frontera, Laredo, Santander, Las Palmas de Gran Canaria, León
2023-11-06
Recruiting
AbbVie
Phase 3
1,500
L'Hospitalet de Llobregat, Fuenlabrada, Barcelona, Córdoba, Madrid, Valencia
2023-10-11
Recruiting
AbbVie
Phase 3
90
Esplugues de Llobregat, Valencia
2023-10-02
Active, closed
AbbVie
Phase 2
130
Santander, Córdoba, Majadahonda, Pamplona, Barcelona, Madrid, Seville, Zaragoza
2023-09-21
Active, closed
AbbVie
Phase 3
1,014
A Coruña, Vigo, Seville
2023-07-25
Active, closed
AbbVie
Phase 3
1,328
L'Hospitalet de Llobregat, Majadahonda, Manises, Barcelona, Granada, Madrid, Valencia
2023-06-21
Active, closed
AbbVie
Phase 1
135
Majadahonda, Barcelona, Madrid, Salamanca
2023-06-09
Active, closed
AbbVie
Observational
1,019
Santiago de Compostela, L'Hospitalet de Llobregat, Santander, Majadahonda, El Palmar, Vigo, Huelva, Madrid
2023-06-09
By invitation
AbbVie
Phase 3
650
Barcelona, Madrid, Seville, Valencia
2023-06-05
Recruiting
AbbVie
Phase 3
450
Barcelona, Madrid, Seville, Valencia
2023-05-01
Active, closed
AbbVie
Phase 1
39
Santander, Madrid
2023-04-26
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma
AbbVie
Phase 1
78
L'Hospitalet de Llobregat, Barcelona, Madrid
2023-04-04
Recruiting
AbbVie
Phase 1
250
Santander, Majadahonda, Salamanca
2023-03-21
Active, closed
AbbVie
Phase 3
520
A Coruña, L'Hospitalet de Llobregat, Córdoba, Málaga, Pamplona, Barcelona, Girona, Madrid
2023-03-15
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
DrugIMGN151
AbbVie
Phase 1
256
Badalona, Córdoba, Barcelona, Madrid, Valencia
2023-01-11
Active, closed
AbbVie
Phase 1
288
Barcelona, Madrid, Seville, Valencia
2022-12-05
Active, closed
AbbVie
Phase 1
283
L'Hospitalet de Llobregat, Pamplona, Barcelona, Madrid, Seville
2022-10-20
Active, closed
AbbVie
Phase 2
125
A Coruña, Badalona, Córdoba, Pamplona, Badajoz, Barcelona, Lleida, Madrid
2022-09-28
Active, closed
AbbVie
Observational
785
L'Hospitalet de Llobregat, Sabadell, Las Palmas de Gran Canaria, Gijón, San Cristóbal de La Laguna, Seville, Galdakao, Almería
2022-08-15
Recruiting
AbbVie
Phase 2
75
Madrid
2022-03-28
Recruiting
AbbVie
Phase 3
768
Las Palmas de Gran Canaria, Alcorcón, Fuenlabrada, Ávila, Barcelona, Jaén, Madrid, Valencia
2022-03-25
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Santiago de Compostela, L'Hospitalet de Llobregat, Córdoba, Las Palmas de Gran Canaria, Majadahonda, Barcelona, Madrid
2022-01-13
Active, closed
AbbVie
Phase 2
210
Manises, Barcelona, Granada, Madrid
2021-12-28
Active, closed
AbbVie
Phase 1
520
Santiago de Compostela, Badalona, Alcorcón, Pamplona, Barcelona, Jaén, Madrid, Seville
2021-10-13
Active, closed
AbbVie
Phase 3
132
Esplugues de Llobregat, Madrid, Pontevedra
2021-07-24
Active, closed
AbbVie
Phase 1
81
Barcelona, Madrid, Majadahonda, Málaga
2021-02-23
Active, closed
AbbVie
Phase 1
21
Barcelona, Madrid
2020-11-11
Active, closed
AbbVie
Phase 3
527
Ferrol, Santiago de Compostela, Badalona, L'Hospitalet de Llobregat, Fuenlabrada, Majadahonda, Oviedo, Alicante
2020-09-30
Active, closed
AbbVie
Phase 3
531
Badalona, Córdoba, Pozuelo de Alarcón, Barcelona, Madrid, Salamanca, Seville, Valencia
2020-09-10
Active, closed
AbbVie
Phase 3
330
A Coruña, Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Oviedo, Barcelona, Granada, Madrid
2020-08-31
Active, closed
AbbVie
Phase 1
85
L'Hospitalet de Llobregat, Pamplona, Madrid
2019-11-08
Active, closed
AbbVie
Phase 1/2
218
Madrid, Valencia
2019-11-06
Active, closed
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
NCT03844048Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma
DrugsVenclexta·Venetoclax
AbbVie
Phase 3
165
Madrid
2019-09-06
Active, closed
AbbVie
Phase 1
124
Esplugues de Llobregat, Madrid, Valencia
2019-06-24
Active, closed
AbbVie
Phase 1
150
Barcelona, Madrid, Málaga
2019-05-21
Active, closed
AbbVie
Phase 3
964
Badalona, Sabadell, A Coruña, Almería, Barcelona, Madrid, Valencia
2019-03-25
Active, closed
AbbVie
Phase 3
444
Sabadell, Santander, A Coruña, Madrid, Valencia
2019-03-07
Active, closed
AbbVie
Phase 1
364
Pamplona, Barcelona, Madrid, Valencia
2019-02-21
Active, closed
AbbVie
Phase 3
265
Palma de Mallorca, Marbella, Ourense, San Cristóbal de La Laguna, Barcelona, Girona, León, Madrid
2018-10-22
Active, closed
AbbVie
Phase 2
270
Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Alcorcón, Ávila, Barcelona, Madrid, Málaga
2018-10-10
Active, closed
AbbVie
Phase 3
1,242
Ferrol, Sabadell, Majadahonda, Vigo, Gijón, Barcelona, Córdoba, Madrid
2018-08-28
Active, closed
AbbVie
Phase 3
1,533
Puerto Real, Alicante, Barcelona, Madrid
2018-08-09
Active, closed
AbbVie
Phase 3
1,336
Ferrol, L'Hospitalet de Llobregat, Sabadell, Majadahonda, Bilbao, Barcelona, Madrid, Salamanca
2018-04-09
Active, closed
AbbVie
Phase 3
747
Palma de Mallorca, Santander, Las Palmas de Gran Canaria, Pamplona, A Coruña, Barcelona, Girona, Huelva
2018-03-21
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Valencia
2018-01-02
Active, closed
AbbVie
Phase 1
163
Majadahonda, Madrid, Valencia
2017-02-22
Active, closed
AbbVie
Phase 3
443
Pamplona, Barcelona, Madrid, Málaga, Valencia
2017-02-02
Active, closed
AbbVie
Phase 3
950
A Coruña, Santiago de Compostela, Santander, Las Palmas de Gran Canaria, Barcelona, Córdoba, Madrid, Salamanca
2017-01-31
Active, closed
AbbVie
Phase 2
120
Badalona, Barcelona, Madrid
2017-01-19
Active, closed
AbbVie
Phase 3
1,629
Santander, A Coruña, Córdoba, Santiago de Compostela
2015-12-01
Active, closed
AbbVie
Observational
1,446
A Coruña, Ferrol, Santiago de Compostela, Palma de Mallorca, Badalona, Esplugues de Llobregat, Sabadell, Leganés
2014-08-28
Rows per page Showing 1–103 of 103
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-spain

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,909 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 103 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Spain?

36 of the 103 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 65 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 103 studies
PhaseStudiesRecruitingShare
Phase 3411139.8%
Phase 2211020.4%
Phase 119418.4%
Observational13612.6%
Phase 2/3645.8%
Phase 1/2312.9%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
AbbVie10336

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Crohn's Disease (8) Multiple Myeloma (6) Chronic Lymphocytic Leukemia (5) Ulcerative Colitis (5) c-MET (4) Hidradenitis Suppurativa (4) Atopic Dermatitis (3) Advanced Solid Tumors Cancer (3) Hepatocellular Carcinoma (3) Non-Small Cell Lung Cancer (3) Advanced Solid Tumors (3) Colorectal Cancer (3) Acute Myeloid Leukemia (3) Ovarian Cancer (3) Fallopian Tube Cancer (3)
→

Browse trials by site location

Madrid (79) Barcelona (58) Valencia (40) Seville (29) Majadahonda (22) Pamplona (20) Málaga (17) Santander (17) Santiago de Compostela (17) Badalona (17) Córdoba (16) A Coruña (16) L'Hospitalet de Llobregat (13) Las Palmas de Gran Canaria (12) Sabadell (10)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.